Intense simplified strategy for newly diagnosed type 2 diabetes in patients with severe hyperglycaemia: multicentre, open label, randomised trial

Liehua Liu(Sun Yat-sen University), Yanbing Li(Sun Yat-sen University), Zhihong Liao(Sun Yat-sen University), Xiuwei Zhang(Dongguan People’s Hospital), Zhaohui Lyu(Chinese PLA General Hospital), Juan Liu(Chongqing Three Gorges Central Hospital), Bing Ji(Emory University), Yan Li(Wannan Medical College), Chaoyan Xu(Sun Yat-sen University), Shen Qu(Shanghai Tenth People's Hospital), Weijian Ke(Sun Yat-sen University), Yongquan Shi(National Clinical Research Center for Digestive Diseases), Yehuda Handelsman(Tarzana Treatment Centers), Shubin Hong(Sun Yat-sen University), Wanping Deng(Sun Yat-sen University), Leili Gao(Peking University), Peiji Dai(Sun Yat-sen University), Jian Kuang(Guangdong General Hospital), Jianhua Ma(Sun Yat-sen University), Fangping Li(South China Agricultural University), Xiaopei Cao(Sun Yat-sen University), Shu Li(Huizhou Central People's Hospital), Hai Li(Affiliated Hospital of Southwest Medical University), Haipeng Xiao(Sun Yat-sen University), Xuesi Wan(Sun Yat-sen University), Shuang Yu(Sun Yat-sen University), Lijuan Xu(Sun Yat-sen University), Guanjie Fan(Guangzhou University of Chinese Medicine), Pengyuan Zhang(Sun Yat-sen University), Zhimin Huang(Nanjing Medical University), Yinghong Du(Panyu District Central Hospital), Yaoming Xue(Southern Medical University), Guohong Wei(Sun Yat-sen University), Yiming Mu(Chinese PLA General Hospital)
BMJ
October 15, 2024
10.1136/bmj-2024-080122
Cited by 17

Related Papers

Consensus Statement By The American Association Of Clinical Endocrinologists And American College Of Endocrinology On The Comprehensive Type 2 Diabetes Management Algorithm – 2016 EXECUTIVE SUMMARY
|Endocrine Practice|2016|875
American Association of Clinical Endocrinologists and American College of Endocrinology – Clinical Practice Guidelines for Developing A Diabetes Mellitus Comprehensive Care Plan – 2015 — Executive Summary
|Endocrine Practice|2015|633
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2020 Executive Summary
|Endocrine Practice|2020|603
Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial
|The Lancet Diabetes & Endocrinology|2017|595
American Association Of Clinical Endocrinologists And American College Of Endocrinology -Clinical Practice Guidelines For Developing A Diabetes Mellitus Comprehensive Care Plan – 2015
|Endocrine Practice|2015|565